本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 证券代码：301283 证券简称：聚胶股份 公告编号：2025-037 聚胶新材料股份有限公司 关于股东减持股份计划预披露公告 股东郑朝阳先生保证向本公司提供的信息内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 二、本次减持计划的主要内容 1、拟减持的原因：股东个人资金安排。 2、拟减持的股份来源：公司首次公开发行前已发行的股份。 3、拟减持数量、占公司总股本的比例：计划减持股份不超过 2,412,534 股（即 不超过公司总股本的 3.00%）；若实施期间有送股、资本公积金转增股本、配股、 注销已回购股份等股份变动事项，拟减持股份数量将相应进行调整。 | 股东名称 | 持有股份的总数量（股） | 占公司总股本的比例 | | --- | --- | --- | | 郑朝阳 | 3,448,422 | 4.29% | 注：其首次公开发行前取得的股份已于 2023 年 9 月 15 日解除限售。 特别提示： 持有聚胶新材料股份有限公司（以下简称"公司"或"本公司"）股份 3,448,422 股（占本公司总股本比例 4.29%）的股东 ...

Group 1 - Qingmu Technology plans to reduce its shareholding by up to 3%, amounting to no more than 2.776 million shares [1] - Newcap received a decision from the police to revoke the case against its actual controller, who was previously detained for insider trading [2] - Rhine Biotech's directors and executives plan to collectively reduce their holdings by up to 0.14%, totaling no more than 1.0185 million shares [3] Group 2 - Puli Tui's stock and convertible bonds will be delisted on May 22, 2025 [5] - *ST Nong Shang will have its delisting risk warning lifted and will resume trading on May 23, 2025 [7] - State Grid Information Communication plans to acquire 100% equity of Yili Technology for approximately 1.853 billion yuan [9] Group 3 - Kelun Pharmaceutical's subsidiary received drug registration approval for a new injectable product, which is the first of its kind in China [10] - Aishida plans to acquire 7% equity of its subsidiary Zhejiang Qianjiang Robot Co., Ltd. for 13.09 million yuan [11] - Hongming Co. is planning to acquire 83% equity of Shenzhen Chisu Automation Equipment Co., Ltd. for approximately 151 million yuan [12] Group 4 - JuJiao Co. plans to reduce its shareholding by up to 2.6%, totaling no more than 2.093 million shares [14] - AVIC Financial's stock will be delisted on May 27, 2025 [16] - Jingwang Electronics' major shareholders plan to reduce their holdings by up to 2.99% [17] Group 5 - Huaren Health intends to acquire stakes in three pharmaceutical chain companies for a total of 327 million yuan [18] - Huanrui Century's original shareholders are required to compensate for unfulfilled performance commitments with 116 million shares [20] - Tefa Service's shareholders plan to reduce their holdings by up to 3% [21] Group 6 - Maipu Medical is planning to acquire at least 51% of Easy Medical's equity, which will constitute a major asset restructuring [22] - *ST Jinshi will have its delisting risk warning lifted and its stock will resume trading on May 23, 2025 [22] - Guoke Micro is planning a major asset restructuring and will suspend trading [23] Group 7 - Defu Technology intends to acquire 100% equity of an overseas electronic circuit copper foil company [24] - Xince Standard's shareholder plans to reduce its holdings by up to 1% [25] - Xiouqiang Co. plans to reduce its holdings by up to 3% [27]

Group 1 - The State Financial Supervision Administration and seven other departments issued measures to support financing for small and micro enterprises, emphasizing the establishment of a coordination mechanism for financing support [1] - The measures include conducting extensive visits to small and micro enterprises to assess their operational status and financing needs, facilitating direct access to bank credit [1] - There is a focus on addressing the operational difficulties faced by small and micro enterprises and encouraging support for key sectors such as foreign trade, private enterprises, technology, and consumption [1] Group 2 - In May 2025, a total of 130 domestic online games were approved by the National Press and Publication Administration [2] Group 3 - The State Council announced the removal of Wang Jianjun from the position of Vice Chairman of the China Securities Regulatory Commission [3] Group 4 - The Shanghai Municipal Government issued a plan to boost consumption, which includes measures to promote reasonable income growth and improve wage distribution mechanisms [4] - The plan aims to enhance the minimum wage adjustment mechanism and support the development of the rural economy and new business models [4] Group 5 - Shanghai is accelerating the introduction of childcare subsidies and maternity social security subsidies as part of its efforts to build a family-friendly society [5] - The city plans to explore increasing parental leave and spouse's paternity leave while enhancing the quality of public kindergartens [5] Group 6 - The Ministry of Foreign Affairs stated that China has the capability and confidence to handle external risks, including tariff wars, as evidenced by a 2.4% year-on-year increase in total goods import and export in the first four months of the year [6] - Exports grew by 7.5%, indicating strong international competitiveness despite high tariff barriers [6] Group 7 - The Ministry of Foreign Affairs expressed strong opposition to the EU's unilateral sanctions against Chinese companies, emphasizing the need for fair trade practices [8] - The ministry highlighted that normal business interactions between Chinese and Russian companies should not be disrupted by these sanctions [8] Group 8 - The Dalian Commodity Exchange announced trading arrangements for the Dragon Boat Festival period, with a market closure from May 31 to June 2, 2025, and a return to normal trading on June 3 [9] Group 9 - Heng Rui Pharmaceutical set the issuance price for its H-shares at HKD 44.05 per share [11] - Xinyuan Technology plans to issue H-shares and list on the Hong Kong Stock Exchange [11] - The company Guokai Microelectronics is planning a major asset restructuring, leading to a suspension of its stock from May 22 [11]

Key Points - Vanke A has signed a supplementary agreement with Shenzhen Metro Group for a loan of up to 4.2 billion yuan, with a pledge of up to 6 billion yuan in shares of its subsidiary, Wanwu Cloud [3] - Heng Rui Pharmaceutical has set the final price for its H-share issuance at 44.05 HKD per share, with plans to list on the Hong Kong Stock Exchange on May 23, 2025 [4] - Wan Dong Medical has elected Ma Chibing as the new chairman after Hu Ziqiang resigned from the position [5] - Tianqi Mould has confirmed that there are no undisclosed significant matters amid ongoing major asset restructuring [6] - Zhejiang Rongtai plans to invest 20 million yuan to establish a wholly-owned subsidiary focused on intelligent robotics [7] - ST Mingcheng intends to publicly transfer 45% of its subsidiary, Time Media, which will no longer be included in the consolidated financial statements [8] - Shanghai Xiba plans to purchase patent assets for 2 million yuan and 500,000 yuan, and establish subsidiaries to promote the commercialization of new technologies [9] - Jushen Co. has received a total of 95.7 million yuan in dividends from its six wholly-owned subsidiaries [10] - ST Asia Pacific has confirmed no undisclosed significant matters or ongoing major plans [11] - Tianrong Tianyu's controlling shareholder's agreement will not be renewed after its expiration [12] - Wangzi New Materials has stated that its energy storage capacitor business is minimal and will not significantly impact its performance [13] - Nanjing Port has clarified that its foreign trade container business does not have direct routes to the U.S. [14] - Jinlongyu has indicated that its solid-state battery business has not yet formed stable long-term revenue [15] - Tianzhihang's subsidiary plans to raise capital by introducing investors [16] - State Grid Information plans to acquire 100% of Yili Technology for 1.853 billion yuan, enhancing its revenue and profit [17] - ST Nongsang will remove its delisting risk warning starting May 23 [18] - Yipin Hong has stated that its innovative drug AR882 has not yet been launched and will not significantly impact recent performance [19] - Huanrui Century has announced a performance compensation plan requiring original shareholders to compensate 116 million shares [20] - Huaren Health plans to acquire stakes in three pharmaceutical chain companies for a total of 3.282 billion yuan [21][22] - Hongming Co. is planning to acquire 83% of Shenzhen Chisu for 1.51 billion yuan [23] - Aishida intends to acquire an additional 7% stake in its subsidiary Qianjiang Robot for 13.09 million yuan [24] - Dasheng Intelligent has signed a contract worth 11.5 million yuan for a high-efficiency machine room project [25] - Jinggu Co. has received a notice to supply wheels for a major global automaker, with expected sales of approximately 158 million USD over ten years [26] - Pingzhi Information has signed a framework agreement with China Mobile for antenna products worth up to 13.01 million yuan [27] - Shanghai Laishi's controlling shareholder plans to increase its stake by 250 million to 500 million yuan [28] - Qixia Construction's shareholder plans to reduce its stake by up to 3% [29] - Sichuan Gold's major shareholders plan to reduce their stakes by up to 5.5% [30] - Qingyun Technology's shareholders plan to reduce their stakes by up to 4.5% [31] - Rhein Biological's directors plan to reduce their stakes by up to 0.14% [32] - Qingmu Technology's shareholder plans to reduce its stake by up to 3% [33] - Sanrenxing's employee shareholding platform plans to reduce its stake by up to 3% [34][35] - Juzhi Technology's director plans to reduce his stake by up to 40,000 shares [36] - Jingwang Electronics' major shareholders plan to reduce their stakes by up to 2.99% [37] - Jujiao Co. plans to reduce its stake by up to 2.6% [38] - Xiyu Tourism's major shareholder plans to reduce its stake by up to 3% [39]

股东名称 持有股份的总数量（股） 占公司总股本的比例 科金聚创 2,093,023 2.60% 证券代码：301283 证券简称：聚胶股份 公告编号：2025-036 聚胶新材料股份有限公司 股东广州科金聚创创业投资合伙企业（有限合伙）保证向本公司提供的信息 内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 持有聚胶新材料股份有限公司（以下简称"公司"或"本公司"）股份 2,093,023 股（占本公司总股本比例 2.60%）的股东广州科金聚创创业投资合伙企业（有限 合伙）计划自本减持计划公告之日起 15 个交易日后的 3 个月内通过集中竞价交 易方式减持本公司股份不超过 804,178 股（即不超过公司总股本的 1.00%）或自 本减持计划公告之日起 3 个交易日后的 3 个月内通过大宗交易方式减持本公司 股份不超过 1,608,356 股（即不超过公司总股本的 2.00%），合计减持不超过 公司于近日收到股东广州科金聚创创业投资合伙企业（有限合伙）（以下简 称"科金聚创"）出具的《关于股份减持计划的告知函》。现将相关 ...

Group 1: Production and Cost Analysis - The production costs of the Guangzhou headquarters factory differ from those of the Poland factory, with the latter being higher due to factors like location and customer positioning [1] - The company maintains a structural cost advantage over competitors through continuous R&D and collaboration with domestic suppliers [1] Group 2: New Product Development - New products such as wet-strength adhesive, next-generation urine-visible adhesive, high-performance multipurpose adhesive, and medical adhesives have been commercialized [2] - Other new products like next-generation soft adhesive, biodegradable hot melt adhesive, bio-based hot melt adhesive, and S rubber special reinforced adhesive are in trial stages with some customers, ready for commercialization [2] Group 3: Market Expansion and Partnerships - The company has established partnerships with Kao and Procter & Gamble, but still has low market share in these collaborations, indicating significant growth potential [3] - The domestic market share in the hot melt adhesive sector is relatively high, but overseas market share remains small, presenting opportunities for expansion [4] Group 4: Strategic Focus and Future Directions - The company aims to enhance brand building and increase its global market influence while expanding market share, particularly in overseas markets [4] - The application fields for hot melt adhesives are extensive, covering various industries, and the company is exploring new application areas to create a second growth curve [4] Group 5: Shareholder Information - The major shareholder, Zibo Fufeng Hongjin Investment Partnership, has not expressed any intention to reduce their holdings, indicating trust in the company [6]

证券代码：301283 证券简称：聚胶股份 公告编号：2025-035 聚胶新材料股份有限公司 关于股东减持股份结果公告 股东郑朝阳先生保证向本公司提供的信息内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 聚胶新材料股份有限公司（以下简称"公司"或"本公司"）于 2025 年 1 月 25 日披露了《关于持股 5%以上股东减持股份计划预披露公告》（公告编号：2025- 003），股东郑朝阳先生计划自本减持计划公告之日起 15 个交易日后的 3 个月内 通过集中竞价交易方式减持本公司股份不超过 800,000 股（即不超过公司当时总 股本的 1.00%）。 公司近日收到股东郑朝阳先生出具的《关于股东减持股份结果告知函》，现 将相关情况公告如下： 3、股东本次减持前后持股情况 注：1、本次减持前持有股份占总股本比例按照公司于 2025 年 1 月 25 日披 露《关于持股 5%以上股东减持股份计划预披露公告》时的公司总股本 80,000,000 股计算； 2、本次减持后持有股份占总股本比例按照本公告日的公司总股本 80,417,82 ...

证券代码：301283 证券简称：聚胶股份 公告编号：2025-036 聚胶新材料股份有限公司 关于公司股东减持股份的预披露公告 股东广州科金聚创创业投资合伙企业（有限合伙）保证向本公司提供的信息 内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 持有聚胶新材料股份有限公司（以下简称"公司"或"本公司"）股份 2,093,023 股（占本公司总股本比例 2.60%）的股东广州科金聚创创业投资合伙企业（有限 合伙）计划自本减持计划公告之日起 15 个交易日后的 3 个月内通过集中竞价交 易方式减持本公司股份不超过 804,178 股（即不超过公司总股本的 1.00%）或自 本减持计划公告之日起 3 个交易日后的 3 个月内通过大宗交易方式减持本公司 股份不超过 1,608,356 股（即不超过公司总股本的 2.00%），合计减持不超过 2,093,023 股，占公司总股本的 2.60%。 公司于近日收到股东广州科金聚创创业投资合伙企业（有限合伙）（以下简 称"科金聚创"）出具的《关于股份减持计划的告知函》。现将相关情况公告 ...

聚胶股份（301283）公告，股东郑朝阳于2025年3月14日至2025年5月20日通过集中竞价交易方式减持公 司股份80万股，占公司目前总股本的0.9948%。此次减持后，郑朝阳持有公司股份数量为344.84万股， 占公司目前总股本的4.2881%，不再为持有公司5%以上股份的股东。 ...

证券代码：301283 证券简称：聚胶股份 公告编号：2025-034 聚胶新材料股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、聚胶新材料股份有限公司（下称"公司"或"本公司"）于 2025 年 5 月 7 日召开 2024 年年度股东大会，审议通过 2024 年度利润分配预案：以公司董事 会审议利润分配方案当日的总股本 80,000,000 股扣除截至当日公司股票回购专 用证券账户已回购股份 851,300 股后的股本 79,148,700 股为基数（最终以实施 2024 年年度利润分配方案时股权登记日公司总股本扣除库存股后的股数为准）， 向全体股东每 10 股派发现金股利人民币 5.00 元（含税），合计拟派发现金股利 人民币 39,574,350.00 元，不送红股，不以资本公积金转增股本。实施上述分配 后，公司剩余可供分配利润结转到以后年度。在本次利润分配方案经公司董事会 审议通过之日至公司权益分派实施日期间，若公司总股本由于可转债转股、股份 回购、股权激励行权、再融资新增股份上市等原因 ...